Small molecules like iFSP1,59 NPD4928,332 and FSEN1333 selectively inhibit FSP1, sensitizing cancer cells to ferroptosis and providing a strategy to enhance therapies resistant to ferroptosis. Here, AIFM2 is linked to cancer.